Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Phase 1
Recruiting
- Conditions
- Renal Cell CarcinomaColorectal CancerHead and Neck CancerMalignant MelanomaBreast CancerCervical Cancer
- Interventions
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- GeneMedicine Co., Ltd.
- Target Recruit Count
- 125
- Registration Number
- NCT06265025
- Locations
- 🇰🇷
National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
🇰🇷Korea University Anam Hospital, Seoul, Korea, Republic of
🇰🇷Hanyang University Seoul Hospital, Seoul, Korea, Republic of
News
No news found